Skip to main content
Figure 5 | Arthritis Research & Therapy

Figure 5

From: Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis

Figure 5

Maintenance of normal levels of nephritis-associated gene expression with sirolimus treatment. Of the 547 probe sets expressed at significantly different levels in diseased and asymptomatic kidney, 365 were not significantly different (false discovery rate (FDR) > 0.05) between asymptomatic and sirolimus-treated kidney. Probe sets are shown ordered by expression level in asymptomatic kidney.

Back to article page